Buspirone pharmacokinetics in patients with cirrhosis.
نویسندگان
چکیده
منابع مشابه
Fleroxacin pharmacokinetics in patients with liver cirrhosis.
In this open-label study, the disposition of fleroxacin in liver disease in 12 healthy male volunteers, 6 male cirrhotics without ascites (group A), and 6 male cirrhotics with ascites (group B) was evaluated. Fleroxacin (400 mg) was administered orally and intravenously to each subject in a random crossover fashion. Fleroxacin was completely absorbed and achieved similar peak concentrations in ...
متن کاملClinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis.
patients with liver dysfunction, plasma AD levels have been found to be elevated and prolonged (5). This elevation and prolongation of plasma AD levels was found to correlate with the elevation of bilinubin, and the ob servation has led to an empirical index for dose adjustments on the basis of liven function as determined by bilirubin and transaminase levels (2). The phanmacokinetic studies us...
متن کاملPharmacokinetics and pharmacodynamics of rapacuronium in patients with cirrhosis.
BACKGROUND Delayed elimination kinetics of steroidal neuromuscular blocking agents have been observed in patients with cirrhosis. Like other steroidal muscle relaxants, rapacuronium may, in part, be eliminated by the liver. To determine the influence of liver disease on its neuromuscular blocking effect, we studied the pharmacokinetics and pharmacodynamics of rapacuronium in patients with cirrh...
متن کاملPharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis.
The pharmacokinetic profiles of atracurium and one of its derivatives, laudanosine were studied following an i.v. bolus of atracurium 0.6 mg kg-1 administered to eight patients with hepatic cirrhosis and to seven healthy controls. The central volume of distribution of atracurium was greater in the patients with cirrhosis (104.6 ml kg-1) compared with the controls (69.6 ml kg-1) (P less than 0.0...
متن کاملPharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis.
The pharmacokinetics of dirithromycin were determined over a 72-h period following oral administration of a single 500-mg dose to 8 healthy volunteers and to 16 cirrhotic patients (8 patients with class A cirrhosis and 8 patients with class B cirrhosis according to Pugh's & Child's classification). Drug levels in plasma and urine were determined by microbiological assay. The mean maximum concen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 1987
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.1987.tb03210.x